Publikationen SOMA.GUT
-
Aktuelle Publikationen
Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: study protocol for a three-arm randomised controlled trial (SOMA.GUT-RCT).
Löwe B, Nestoriuc, Y, Andresen V, Vettorazzi E, Zapf A, Hübener S, Maheder K, Peters L, Lohse AW.
BMJ OPEN 2022;12:e059529. doi: 10.1136/bmjopen-2021-059529Psychosoziale Unterstützung von Menschen mit Colitis ulcerosa und Reizdarmsyndrom: eine Machbarkeitsstudie zu Bedarf, Fokus und Durchführbarkeit.
Uhlenbusch N, Manthey C, Nestoriuc Y, Andresen V, Lohse AW, Löwe B.
PSYCHOTHER PSYCH MED. 2022; doi: 10.1055/a-1785-5496 -
Vorarbeiten
Optimizing expectations about cancer treatment: Results of the randomized controlled PSY-BREAST trial.
Shedden-Mora MC, Pan Y, Heisig SR, Blanckenburg Pv, Rief W, Witzel I, Albert US, Nestoriuc Y.
CLIN PSYCH EUROPE. 2020;2(1):e2695.Functional somatic disorders: discussion paper for a new common classification for research and clinical use.
Burton C, Fink P, Henningsen P, Löwe B, Rief W, EURONET-SOMA GROUP.
BMC MEDICINE. 2020;18:34-34.Non-concealed placebo treatment for menopausal hot flushes: Study protocol of a randomized-controlled trial.
Pan Y, Meister R, Löwe B, Winkelmann A, Kaptchuk TJ, Buhling KJ, Nestoriuc Y.
TRIALS. 2019;20(1):508.The Development of Irritable Bowel Syndrome: A Prospective Community-Based Cohort Study.
Löwe B, Lohse A, Andresen V, Vettorazzi E, Rose M, Broicher W.
AM J GASROENTEROL. 2016;111:1320-1329.Determinants and frequency of irritable bowel syndrome in a German sample.
Althaus A, Broicher W, Wittkamp P, Andresen V, Lohse AW, Löwe B.
Z GASTROENTEROL. 2016;54:217-225.Post-infectious irritable bowel syndrome (PI-IBS) after infection with Shiga-like toxin-producing Escherichia coli (STEC) O104:H4: A cohort study with prospective follow-up.
Andresen V, Löwe B, Broicher W, Riegel B, Fraedrich K, von Wulffen M, Gappmayer K, Wegscheider K, Treszl A, Rose M, Layer P, Lohse AW.
UNITED EUROPEAN GASTROENTEROL J. 2016;4:121-131.Acute Ebola virus disease patient treatment and health-related quality of life in health care professionals: A controlled study.
Lehmann M, Brünahl CA, Addo MM, Becker S, Schmiedel S, Lohse AW, Schramm C, Löwe B.
J PSYCHOSOM RES. 2016;83:69-74.Is it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study.
Nestoriuc Y, von Blanckenburg P, Schuricht F, Barsky AJ, Hadji P, Albert US, Rief W.
ANN ONCOL. 2016;27:1909-1915.Psychological outcome, fatigue, and quality of life after infection with shiga toxin-producing Escherichia coli O104.
Löwe B, Andresen V, Fraedrich K, Gappmayer K, Wegscheider K, Treszl A, Riegel B, Rose M, Lohse AW, Broicher W.
CLIN GASTROENTEROL HEPATOL. 2014;12:1848-1855.Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis.
Schramm C, Wahl I, Weiler-Normann C, Voigt K, Wiegard C, Glaubke C, Brähler E, Löwe B, Lohse AW, Rose M.
J HEPATOL. 2014;60:618-624. -
Vorträge
Persistence of Gastrointestinal Symptoms in Irritable Bowel Syndrome and Ulcerative Colitis: From Risk Factors to Modification.
Löwe B, Lohse AW, Andresen V, Nestoriuc Y, Maehder K, Peters L, Hübener S.
DGNM-Jahresmeeting, Berlin, 5. März 2023.
[Vortrag]